FDA Commissioner States Examination of Law Might Lower Drug Prices


FDA Commissioner pic

FDA Commissioner
Image: fda.gov

Ashok Pinnamaraju graduated from St. Cloud State University and Oregon State University before embarking on a pharmacy career that has spanned more than a decade. Currently the owner of Virginia-based Williamson Road Pharmacy, Ashok Pinnamaraju devotes himself to customer service by ensuring customers receive the right prescription drugs at the best available prices.

The cost of health care in the United States has been a hot topic of conversation over the years, and the price of prescription drugs has been a major part of that discussion. According to recent reports, the FDA may be looking at changes in the law that could lead to an overall reduction in prescription drug prices.

The law in question involves the way that prescription drug rebates are classified at the federal level. Currently, many prescription drug manufacturers offer rebate programs to pharmacy benefit managers and insurance companies in exchange for placement on preferred drug lists. The FDA argues that this should be treated as an illegal kickback.

FDA commissioner Scott Gottlieb stated in a recent speech that, by eliminating these rebate programs, insurers and pharmacy benefit managers could negotiate a better deal with drug manufacturers. These savings would then be passed on to consumers in the form of lower prices.